Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Supplement

铁硫簇对代谢和基因表达的调节 - 补充

基本信息

项目摘要

Project Summary/Abstract (from original application) Iron-sulfur clusters (ISCs) are essential protein cofactors whose dysregulation is linked to a wide range of debilitating diseases including Friedrch’s ataxia. This pathology is due in part to the use of ISCs in iron responsive proteins (IRPs), which control the translation of mRNAs in the iron-starvation response. We recently found that by suppressing ISC biosynthesis we can robustly activate this IRP-mediated iron-starvation response, sensitizing cancer cells to cell death by ferroptosis. Our preliminary data, which form the premise of our application, point to an unexpected mode of IRP2 regulation by ISCs and demonstrate that the mechanism by which ISCs modulate the iron-starvation response, and therefore impact human disease, remains unclear. Our long-term goal is to dissect the mechanisms by which ISCs regulates cellular responses to changing iron and oxygen availability and how this response is mediated by IRPs. We anticipate that these discoveries will lead to the identification of pathologies for diseases where prior ISC involvement was unclear, to new treatments for diseases of ISC dysregulation, and will facilitate novel methods to sensitize cancer cells to ferroptosis. The objective of this grant is to dissect how ISCs control IRP2 activation and to comprehensively define the targets of IRP1 and IRP2 and the conditions under which they are activated. Our overarching hypothesis is that ISCs integrate iron and oxygen level inputs to effect specific translational responses via differential regulation of IRPs. Our rationale is that identification of the specific mechanisms by which IRPs are activated and the targets that they activate will enable the discovery of novel strategies to treat cancer and disorders of ISC metabolism. Our specific aims will test the following hypotheses: (Aim 1) ISCs can activate the iron-starvation response through an IRP2-mediated mechanism; (Aim 2) IRPs exhibit differential IRE binding in response to iron and oxygen level modulation. Upon completion of these aims we will (1) gain an understanding of how cells sense iron and oxygen levels and integrate these inputs using ISC sensors and (2) identify IRP regulated target genes and the conditions in which they are regulated. This contribution is significant because dysregulation of IRPs occurs frequently in human pathologies, and inducing activation of the iron starvation response sensitizes cancer cells to ferroptotic cell death. This research is innovative because we challenge paradigms in cellular iron-sensing to arrive at a comprehensive mechanism by which cells respond to changes in the level of this important nutrient, and because we utilize heretofore unique approaches to identify RNAs regulated by the iron starvation response and define their activation by upstream stimuli. The outcomes of this study promise disrupt our understanding of iron sensing and have broad implications for the treatment of cancer as well as human diseases related to defects in iron metabolism and storage.
项目摘要/摘要(原申请书)

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5.
  • DOI:
    10.1126/sciadv.abg4302
  • 发表时间:
    2021-05
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
    Terzi EM;Sviderskiy VO;Alvarez SW;Whiten GC;Possemato R
  • 通讯作者:
    Possemato R
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Lewis Possemato其他文献

Richard Lewis Possemato的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Lewis Possemato', 18)}}的其他基金

Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1
铁硫簇对代谢和基因表达的调节 - 重新提交 - 1
  • 批准号:
    9885268
  • 财政年份:
    2020
  • 资助金额:
    $ 5.5万
  • 项目类别:
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1
铁硫簇对代谢和基因表达的调节 - 重新提交 - 1
  • 批准号:
    10539296
  • 财政年份:
    2020
  • 资助金额:
    $ 5.5万
  • 项目类别:
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1
铁硫簇对代谢和基因表达的调节 - 重新提交 - 1
  • 批准号:
    10227441
  • 财政年份:
    2020
  • 资助金额:
    $ 5.5万
  • 项目类别:
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Supplement
铁硫簇对代谢和基因表达的调节 - 补充
  • 批准号:
    10669888
  • 财政年份:
    2020
  • 资助金额:
    $ 5.5万
  • 项目类别:
Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1
铁硫簇对代谢和基因表达的调节 - 重新提交 - 1
  • 批准号:
    10534796
  • 财政年份:
    2020
  • 资助金额:
    $ 5.5万
  • 项目类别:
Targeting Metabolic Liabilities in Cancer
针对癌症的代谢负担
  • 批准号:
    10079472
  • 财政年份:
    2018
  • 资助金额:
    $ 5.5万
  • 项目类别:
Targeting Metabolic Liabilities in Cancer
针对癌症的代谢负担
  • 批准号:
    10328918
  • 财政年份:
    2018
  • 资助金额:
    $ 5.5万
  • 项目类别:
Rapid Determination of Phenotypic Responses Across Cancer Cell Lines
快速测定癌细胞系的表型反应
  • 批准号:
    8959212
  • 财政年份:
    2015
  • 资助金额:
    $ 5.5万
  • 项目类别:
Identification of Metabolic Liabilities in Breast Cancer
乳腺癌代谢负担的识别
  • 批准号:
    8920191
  • 财政年份:
    2014
  • 资助金额:
    $ 5.5万
  • 项目类别:
Identification of Metabolic Liabilities in Breast Cancer
乳腺癌代谢负担的识别
  • 批准号:
    8352910
  • 财政年份:
    2012
  • 资助金额:
    $ 5.5万
  • 项目类别:

相似海外基金

How exercise improves ataxia in SCA6
运动如何改善 SCA6 的共济失调
  • 批准号:
    479005
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
    Operating Grants
Role of POU4F1 in a Novel Form of Ataxia
POU4F1 在新型共济失调中的作用
  • 批准号:
    10741382
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
Exploratoin of Nrf2 activators that potentiate chaperone-mediated autophagy and are useful for the treatment of spinocrebellar ataxia
探索增强伴侣介导的自噬并可用于治疗脊髓小脑共济失调的 Nrf2 激活剂
  • 批准号:
    23K06161
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
  • 批准号:
    10799992
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
  • 批准号:
    10607414
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
  • 批准号:
    10753403
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
  • 批准号:
    10668768
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
  • 批准号:
    10579736
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
The Impact of Vitamin D on mTOR Signaling, Seizures, and Motor Behavior in a Mouse Model of Hyperactive mTOR Induced Epilepsy and Ataxia
维生素 D 对 mTOR 过度活跃诱发癫痫和共济失调小鼠模型中 mTOR 信号传导、癫痫发作和运动行为的影响
  • 批准号:
    10754319
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
  • 批准号:
    10740682
  • 财政年份:
    2023
  • 资助金额:
    $ 5.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了